Clinical Trials Browser

Phase 3 × UNKNOWN × Carcinoma, Small Cell × Clear all

NCT02688036 2018-01-02

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Phase 3 Unknown

Lung Neoplasms, Carcinoma, Small Cell